These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8141839)

  • 1. Phenotypic expression of familial hypercholesterolaemia in central and southern Tunisia.
    Slimane MN; Pousse H; Maatoug F; Hammami M; Ben Farhat MH
    Atherosclerosis; 1993 Dec; 104(1-2):153-8. PubMed ID: 8141839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.
    Jelassi A; Slimani A; Jguirim I; Najah M; Abid A; Boughamoura L; Mzid J; Fkih M; Maatouk F; Rouis M; Varret M; Slimane MN
    Clin Chim Acta; 2010 May; 411(9-10):735-8. PubMed ID: 20144596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous familial hypercholesterolemia among French Canadians in Québec Province.
    Moorjani S; Roy M; Gagné C; Davignon J; Brun D; Toussaint M; Lambert M; Campeau L; Blaichman S; Lupien P
    Arteriosclerosis; 1989; 9(2):211-6. PubMed ID: 2923577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families.
    Slimane MN; Lestavel S; Sun X; Maatouk F; Soutar AK; Ben Farhat MH; Clavey V; Benlian P; Hammami M
    Atherosclerosis; 2001 Feb; 154(3):557-65. PubMed ID: 11257256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
    Heath KE; Gudnason V; Humphries SE; Seed M
    Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A host of hypercholesterolaemic homozygotes in South Africa.
    Seftel HC; Baker SG; Sandler MP; Forman MB; Joffe BI; Mendelsohn D; Jenkins T; Mieny CJ
    Br Med J; 1980 Sep; 281(6241):633-6. PubMed ID: 7437743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia.
    Raal FJ; Areias AJ; Waisberg R; von Arb M
    Atherosclerosis; 1995 May; 115(1):9-15. PubMed ID: 7669091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic basis of familial hypercholesterolemia.
    Myant NB
    Klin Wochenschr; 1983 Apr; 61(8):383-401. PubMed ID: 6306334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y; Leitersdorf E
    Genet Epidemiol; 1996; 13(2):159-77. PubMed ID: 8722744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
    Soutar AK; McCarthy SN; Seed M; Knight BL
    J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.
    Sjouke B; Kusters DM; Kindt I; Besseling J; Defesche JC; Sijbrands EJ; Roeters van Lennep JE; Stalenhoef AF; Wiegman A; de Graaf J; Fouchier SW; Kastelein JJ; Hovingh GK
    Eur Heart J; 2015 Mar; 36(9):560-5. PubMed ID: 24585268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
    Ceska R; Vrablík M; Horínek A
    Physiol Res; 2000; 49 Suppl 1():S125-30. PubMed ID: 10984082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rising cholesterol levels in children with familial hypercholesterolaemia.
    Kessling AM; Seed M; Taylor R; Wynn V; Humphries SE
    Biomed Pharmacother; 1990; 44(7):373-9. PubMed ID: 2268697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
    Scartezini M; Hubbart C; Whittall RA; Cooper JA; Neil AH; Humphries SE
    Clin Sci (Lond); 2007 Dec; 113(11):435-41. PubMed ID: 17550346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.